APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hemostatic and Tissue Sealing Agents

Hemostasis is defined as "the blocking of bleeding or bleeding through blood vessels or other parts of the body".Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually lead to surgery for patients, which in turn promotes the development of the hemostasis and tissue sealant industries.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hemostasis is defined as "the blocking of bleeding or bleeding through blood vessels or other parts of the body".Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually lead to surgery for patients, which in turn promotes the development of the hemostasis and tissue sealant industries.

Selected research

Market Structure

Global Hemostatic and Tissue Sealing Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173908130328 December 2025192 pages

Choose your research edition.

Industry ResearchHemostatic and Tissue Sealing Agents Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemostatic and Tissue Sealing Agents Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Hemostatic and Tissue Sealing Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemostatic and Tissue Sealing Agents Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemostatic and Tissue Sealing Agents Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

Hemostasis is defined as "the blocking of bleeding or bleeding through blood vessels or other parts of the body".Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually lead to surgery for patients, which in turn promotes the development of the hemostasis and tissue sealant industries.

Global Hemostatic and Tissue Sealing Agents key players include J&J, Baxter, C R Bard, etc. Global top three manufacturers hold a share over 45%.

North America is the largest market, with a share about 60%, followed by China, and Europe, both have a share about 30 percent.

Read the full market overview

In terms of product, Hemostatic is the largest segment, with a share about 75%. And in terms of application, the largest application is General Surgery, followed by Minimally Invasive Surgery, etc.

This report provides an overview of the global Hemostatic and Tissue Sealing Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hemostatic and Tissue Sealing Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hemostatic and Tissue Sealing Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hemostatic and Tissue Sealing Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Hemostatic and Tissue Sealing Agents Segment by Company

J&J

Baxter

C R Bard

B Braun

Integra Life Sciences

Advance Medical Solution

CSL Behring

CryoLife

Zimmer Biomet

Pfizer

Medtronic

Smith & Nephew

Cohera Medical

Shanghai Haohai Biological Technology Co. Ltd.

Shandong Saikesaisi Biotechnology Co., Ltd

Chang ShaHai Run biological technology Co, LTD

Hemostatic and Tissue Sealing Agents Segment by Type

Hemostatic

Sealant Gum

Hemostatic and Tissue Sealing Agents Segment by Application

Minimally Invasive Surgery

General Surgery

Other

Hemostatic and Tissue Sealing Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostatic and Tissue Sealing Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemostatic and Tissue Sealing Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostatic and Tissue Sealing Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hemostatic and Tissue Sealing Agents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hemostatic and Tissue Sealing Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hemostatic and Tissue Sealing Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hemostatic and Tissue Sealing Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hemostatic and Tissue Sealing Agents Industry Trends Table 2. Hemostatic and Tissue Sealing Agents Industry Drivers Table 3. Hemostatic and Tissue Sealing Agents Industry Opportunities and Challenges Table 4. Hemostatic and Tissue Sealing Agents Industry Restraints Table 5. Global Hemostatic and Tissue Sealing Agents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hemostatic and Tissue Sealing Agents Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Manufacturers Table 9. Global Hemostatic and Tissue Sealing Agents Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Hemostatic and Tissue Sealing Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hemostatic and Tissue Sealing Agents Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hemostatic and Tissue Sealing Agents Manufacturers, Product Type & Application Table 13. Global Hemostatic and Tissue Sealing Agents Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hemostatic and Tissue Sealing Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Hemostatic Table 17. Major Manufacturers of Sealant Gum Table 18. Global Hemostatic and Tissue Sealing Agents Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Hemostatic and Tissue Sealing Agents Sales by Type (2021-2026) & (K Units) Table 20. Global Hemostatic and Tissue Sealing Agents Sales by Type (2027-2032) & (K Units) Table 21. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2021-2026) Table 22. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2027-2032) Table 23. Global Hemostatic and Tissue Sealing Agents Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Hemostatic and Tissue Sealing Agents Revenue by Type (2021-2026) & (K Units) Table 25. Global Hemostatic and Tissue Sealing Agents Revenue by Type (2027-2032) & (K Units) Table 26. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Type (2021-2026) Table 27. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Minimally Invasive Surgery Table 29. Major Manufacturers of General Surgery Table 30. Major Manufacturers of Other Table 31. Global Hemostatic and Tissue Sealing Agents Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Hemostatic and Tissue Sealing Agents Sales by Application (2021-2026) & (K Units) Table 33. Global Hemostatic and Tissue Sealing Agents Sales by Application (2027-2032) & (K Units) Table 34. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2021-2026) Table 35. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2027-2032) Table 36. Global Hemostatic and Tissue Sealing Agents Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Hemostatic and Tissue Sealing Agents Revenue by Application (2021-2026) & (K Units) Table 38. Global Hemostatic and Tissue Sealing Agents Revenue by Application (2027-2032) & (K Units) Table 39. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Application (2021-2026) Table 40. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Application (2027-2032) Table 41. Global Hemostatic and Tissue Sealing Agents Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Hemostatic and Tissue Sealing Agents Sales by Region (2021-2026) & (K Units) Table 43. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Region (2021-2026) Table 44. Global Hemostatic and Tissue Sealing Agents Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Hemostatic and Tissue Sealing Agents Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Hemostatic and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Hemostatic and Tissue Sealing Agents Sales by Country (2021-2026) & (K Units) Table 48. North America Hemostatic and Tissue Sealing Agents Sales by Country (2027-2032) & (K Units) Table 49. Europe Hemostatic and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Hemostatic and Tissue Sealing Agents Sales by Country (2021-2026) & (K Units) Table 51. Europe Hemostatic and Tissue Sealing Agents Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Hemostatic and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Hemostatic and Tissue Sealing Agents Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Hemostatic and Tissue Sealing Agents Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Hemostatic and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Hemostatic and Tissue Sealing Agents Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Hemostatic and Tissue Sealing Agents Sales by Country (2027-2032) & (K Units) Table 58. Global Hemostatic and Tissue Sealing Agents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Hemostatic and Tissue Sealing Agents Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Hemostatic and Tissue Sealing Agents Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Region (2021-2026) Table 62. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Region (2027-2032) Table 63. J&J Company Information Table 64. J&J Business Overview Table 65. J&J Hemostatic and Tissue Sealing Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. J&J Hemostatic and Tissue Sealing Agents Product Portfolio Table 67. J&J Recent Development Table 68. Baxter Company Information Table 69. Baxter Business Overview Table 70. Baxter Hemostatic and Tissue Sealing Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Baxter Hemostatic and Tissue Sealing Agents Product Portfolio Table 72. Baxter Recent Development Table 73. C R Bard Company Information Table 74. C R Bard Business Overview Table 75. C R Bard Hemostatic and Tissue Sealing Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. C R Bard Hemostatic and Tissue Sealing Agents Product Portfolio Table 77. C R Bard Recent Development Table 78. B Braun Company Information Table 79. B Braun Business Overview Table 80. B Braun Hemostatic and Tissue Sealing Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. B Braun Hemostatic and Tissue Sealing Agents Product Portfolio Table 82. B Braun Recent Development Table 83. Integra Life Sciences Company Information Table 84. Integra Life Sciences Business Overview Table 85. Integra Life Sciences Hemostatic and Tissue Sealing Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Integra Life Sciences Hemostatic and Tissue Sealing Agents Product Portfolio Table 87. Integra Life Sciences Recent Development Table 88. Advance Medical Solution Company Information Table 89. Advance Medical Solution Business Overview Table 90. Advance Medical Solution Hemostatic and Tissue Sealing Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Advance Medical Solution Hemostatic and Tissue Sealing Agents Product Portfolio Table 92. Advance Medical Solution Recent Development Table 93. CSL Behring Company Information Table 94. CSL Behring Business Overview Table 95. CSL Behring Hemostatic and Tissue Sealing Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. CSL Behring Hemostatic and Tissue Sealing Agents Product Portfolio Table 97. CSL Behring Recent Development Table 98. CryoLife Company Information Table 99. CryoLife Business Overview Table 100. CryoLife Hemostatic and Tissue Sealing Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. CryoLife Hemostatic and Tissue Sealing Agents Product Portfolio Table 102. CryoLife Recent Development Table 103. Zimmer Biomet Company Information Table 104. Zimmer Biomet Business Overview Table 105. Zimmer Biomet Hemostatic and Tissue Sealing Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Zimmer Biomet Hemostatic and Tissue Sealing Agents Product Portfolio Table 107. Zimmer Biomet Recent Development Table 108. Pfizer Company Information Table 109. Pfizer Business Overview Table 110. Pfizer Hemostatic and Tissue Sealing Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Pfizer Hemostatic and Tissue Sealing Agents Product Portfolio Table 112. Pfizer Recent Development Table 113. Medtronic Company Information Table 114. Medtronic Business Overview Table 115. Medtronic Hemostatic and Tissue Sealing Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Medtronic Hemostatic and Tissue Sealing Agents Product Portfolio Table 117. Medtronic Recent Development Table 118. Smith & Nephew Company Information Table 119. Smith & Nephew Business Overview Table 120. Smith & Nephew Hemostatic and Tissue Sealing Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Smith & Nephew Hemostatic and Tissue Sealing Agents Product Portfolio Table 122. Smith & Nephew Recent Development Table 123. Cohera Medical Company Information Table 124. Cohera Medical Business Overview Table 125. Cohera Medical Hemostatic and Tissue Sealing Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Cohera Medical Hemostatic and Tissue Sealing Agents Product Portfolio Table 127. Cohera Medical Recent Development Table 128. Shanghai Haohai Biological Technology Co. Ltd. Company Information Table 129. Shanghai Haohai Biological Technology Co. Ltd. Business Overview Table 130. Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Product Portfolio Table 132. Shanghai Haohai Biological Technology Co. Ltd. Recent Development Table 133. Shandong Saikesaisi Biotechnology Co., Ltd Company Information Table 134. Shandong Saikesaisi Biotechnology Co., Ltd Business Overview Table 135. Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Product Portfolio Table 137. Shandong Saikesaisi Biotechnology Co., Ltd Recent Development Table 138. Chang ShaHai Run biological technology Co, LTD Company Information Table 139. Chang ShaHai Run biological technology Co, LTD Business Overview Table 140. Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Product Portfolio Table 142. Chang ShaHai Run biological technology Co, LTD Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Hemostatic and Tissue Sealing Agents Distributors List Table 146. Hemostatic and Tissue Sealing Agents Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Hemostatic and Tissue Sealing Agents Product Image Figure 2. Global Hemostatic and Tissue Sealing Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemostatic and Tissue Sealing Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Hemostatic and Tissue Sealing Agents Sales (2021-2032) & (K Units) Figure 5. Global Hemostatic and Tissue Sealing Agents Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hemostatic and Tissue Sealing Agents Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Hemostatic Image Figure 9. Sealant Gum Image Figure 10. Global Hemostatic and Tissue Sealing Agents Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Hemostatic and Tissue Sealing Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2021-2032) Figure 13. Global Hemostatic and Tissue Sealing Agents Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Hemostatic and Tissue Sealing Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Type (2021-2032) Figure 16. Minimally Invasive Surgery Image Figure 17. General Surgery Image Figure 18. Other Image Figure 19. Global Hemostatic and Tissue Sealing Agents Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Hemostatic and Tissue Sealing Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2021-2032) Figure 22. Global Hemostatic and Tissue Sealing Agents Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Hemostatic and Tissue Sealing Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Application (2021-2032) Figure 25. North America Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2021-2032) Figure 27. U.S. Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2021-2032) Figure 32. Germany Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2021-2032) Figure 39. China Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Hemostatic and Tissue Sealing Agents Sales Market Share by Country (2021-2032) Figure 47. Brazil Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Hemostatic and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Hemostatic and Tissue Sealing Agents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Hemostatic and Tissue Sealing Agents Revenue (2021-2032) & (US$ Million) Figure 58. North America Hemostatic and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Hemostatic and Tissue Sealing Agents Revenue (2021-2032) & (US$ Million) Figure 60. Europe Hemostatic and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Hemostatic and Tissue Sealing Agents Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Hemostatic and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Hemostatic and Tissue Sealing Agents Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Hemostatic and Tissue Sealing Agents Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Hemostatic
  • Sealant Gum
Applications
  • Minimally Invasive Surgery
  • General Surgery
  • Other
Companies covered
  • J&J
  • Baxter
  • C R Bard
  • B Braun
  • Integra Life Sciences
  • Advance Medical Solution
  • CSL Behring
  • CryoLife
  • Zimmer Biomet
  • Pfizer
  • Medtronic
  • Smith & Nephew
  • Cohera Medical
  • Shanghai Haohai Biological Technology Co. Ltd.
  • Shandong Saikesaisi Biotechnology Co., Ltd
  • Chang ShaHai Run biological technology Co, LTD

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hemostatic and Tissue Sealing Agents Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hemostatic and Tissue Sealing Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hemostatic and Tissue Sealing Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hemostatic and Tissue Sealing Agents Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hemostatic and Tissue Sealing Agents Market Dynamics
  1. 2.1 Hemostatic and Tissue Sealing Agents Industry Trends
  2. 2.2 Hemostatic and Tissue Sealing Agents Industry Drivers
  3. 2.3 Hemostatic and Tissue Sealing Agents Industry Opportunities and Challenges
  4. 2.4 Hemostatic and Tissue Sealing Agents Industry Restraints
3 Hemostatic and Tissue Sealing Agents Market by Manufacturers
  1. 3.1 Global Hemostatic and Tissue Sealing Agents Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hemostatic and Tissue Sealing Agents Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hemostatic and Tissue Sealing Agents Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hemostatic and Tissue Sealing Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hemostatic and Tissue Sealing Agents Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hemostatic and Tissue Sealing Agents Manufacturers, Product Type & Application
  7. 3.7 Global Hemostatic and Tissue Sealing Agents Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hemostatic and Tissue Sealing Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hemostatic and Tissue Sealing Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hemostatic and Tissue Sealing Agents Tier 1, Tier 2, and Tier 3
4 Hemostatic and Tissue Sealing Agents Market by Type
  1. 4.1 Hemostatic and Tissue Sealing Agents Type Introduction
  2. 4.1.1 Hemostatic
  3. 4.1.2 Sealant Gum
  4. 4.2 Global Hemostatic and Tissue Sealing Agents Sales by Type
  5. 4.2.1 Global Hemostatic and Tissue Sealing Agents Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hemostatic and Tissue Sealing Agents Sales by Type (2021-2032)
  7. 4.2.3 Global Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2021-2032)
  8. 4.3 Global Hemostatic and Tissue Sealing Agents Revenue by Type
  9. 4.3.1 Global Hemostatic and Tissue Sealing Agents Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hemostatic and Tissue Sealing Agents Revenue by Type (2021-2032)
  11. 4.3.3 Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Type (2021-2032)
5 Hemostatic and Tissue Sealing Agents Market by Application
  1. 5.1 Hemostatic and Tissue Sealing Agents Application Introduction
  2. 5.1.1 Minimally Invasive Surgery
  3. 5.1.2 General Surgery
  4. 5.1.3 Other
  5. 5.2 Global Hemostatic and Tissue Sealing Agents Sales by Application
  6. 5.2.1 Global Hemostatic and Tissue Sealing Agents Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hemostatic and Tissue Sealing Agents Sales by Application (2021-2032)
  8. 5.2.3 Global Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2021-2032)
  9. 5.3 Global Hemostatic and Tissue Sealing Agents Revenue by Application
  10. 5.3.1 Global Hemostatic and Tissue Sealing Agents Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Hemostatic and Tissue Sealing Agents Revenue by Application (2021-2032)
  12. 5.3.3 Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Application (2021-2032)
6 Global Hemostatic and Tissue Sealing Agents Sales by Region
  1. 6.1 Global Hemostatic and Tissue Sealing Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hemostatic and Tissue Sealing Agents Sales by Region (2021-2032)
  3. 6.2.1 Global Hemostatic and Tissue Sealing Agents Sales by Region (2021-2026)
  4. 6.2.2 Global Hemostatic and Tissue Sealing Agents Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hemostatic and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hemostatic and Tissue Sealing Agents Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hemostatic and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hemostatic and Tissue Sealing Agents Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hemostatic and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hemostatic and Tissue Sealing Agents Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hemostatic and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hemostatic and Tissue Sealing Agents Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hemostatic and Tissue Sealing Agents Revenue by Region
  1. 7.1 Global Hemostatic and Tissue Sealing Agents Revenue by Region
  2. 7.1.1 Global Hemostatic and Tissue Sealing Agents Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hemostatic and Tissue Sealing Agents Revenue by Region (2021-2026)
  4. 7.1.3 Global Hemostatic and Tissue Sealing Agents Revenue by Region (2027-2032)
  5. 7.1.4 Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hemostatic and Tissue Sealing Agents Revenue (2021-2032)
  8. 7.2.2 North America Hemostatic and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hemostatic and Tissue Sealing Agents Revenue (2021-2032)
  11. 7.3.2 Europe Hemostatic and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hemostatic and Tissue Sealing Agents Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hemostatic and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 J&J
  2. 8.1.1 J&J Company Information
  3. 8.1.2 J&J Business Overview
  4. 8.1.3 J&J Hemostatic and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 J&J Hemostatic and Tissue Sealing Agents Product Portfolio
  6. 8.1.5 J&J Recent Developments
  7. 8.2 Baxter
  8. 8.2.1 Baxter Company Information
  9. 8.2.2 Baxter Business Overview
  10. 8.2.3 Baxter Hemostatic and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Baxter Hemostatic and Tissue Sealing Agents Product Portfolio
  12. 8.2.5 Baxter Recent Developments
  13. 8.3 C R Bard
  14. 8.3.1 C R Bard Company Information
  15. 8.3.2 C R Bard Business Overview
  16. 8.3.3 C R Bard Hemostatic and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 C R Bard Hemostatic and Tissue Sealing Agents Product Portfolio
  18. 8.3.5 C R Bard Recent Developments
  19. 8.4 B Braun
  20. 8.4.1 B Braun Company Information
  21. 8.4.2 B Braun Business Overview
  22. 8.4.3 B Braun Hemostatic and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 B Braun Hemostatic and Tissue Sealing Agents Product Portfolio
  24. 8.4.5 B Braun Recent Developments
  25. 8.5 Integra Life Sciences
  26. 8.5.1 Integra Life Sciences Company Information
  27. 8.5.2 Integra Life Sciences Business Overview
  28. 8.5.3 Integra Life Sciences Hemostatic and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Integra Life Sciences Hemostatic and Tissue Sealing Agents Product Portfolio
  30. 8.5.5 Integra Life Sciences Recent Developments
  31. 8.6 Advance Medical Solution
  32. 8.6.1 Advance Medical Solution Company Information
  33. 8.6.2 Advance Medical Solution Business Overview
  34. 8.6.3 Advance Medical Solution Hemostatic and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Advance Medical Solution Hemostatic and Tissue Sealing Agents Product Portfolio
  36. 8.6.5 Advance Medical Solution Recent Developments
  37. 8.7 CSL Behring
  38. 8.7.1 CSL Behring Company Information
  39. 8.7.2 CSL Behring Business Overview
  40. 8.7.3 CSL Behring Hemostatic and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CSL Behring Hemostatic and Tissue Sealing Agents Product Portfolio
  42. 8.7.5 CSL Behring Recent Developments
  43. 8.8 CryoLife
  44. 8.8.1 CryoLife Company Information
  45. 8.8.2 CryoLife Business Overview
  46. 8.8.3 CryoLife Hemostatic and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CryoLife Hemostatic and Tissue Sealing Agents Product Portfolio
  48. 8.8.5 CryoLife Recent Developments
  49. 8.9 Zimmer Biomet
  50. 8.9.1 Zimmer Biomet Company Information
  51. 8.9.2 Zimmer Biomet Business Overview
  52. 8.9.3 Zimmer Biomet Hemostatic and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Zimmer Biomet Hemostatic and Tissue Sealing Agents Product Portfolio
  54. 8.9.5 Zimmer Biomet Recent Developments
  55. 8.10 Pfizer
  56. 8.10.1 Pfizer Company Information
  57. 8.10.2 Pfizer Business Overview
  58. 8.10.3 Pfizer Hemostatic and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pfizer Hemostatic and Tissue Sealing Agents Product Portfolio
  60. 8.10.5 Pfizer Recent Developments
  61. 8.11 Medtronic
  62. 8.11.1 Medtronic Company Information
  63. 8.11.2 Medtronic Business Overview
  64. 8.11.3 Medtronic Hemostatic and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Medtronic Hemostatic and Tissue Sealing Agents Product Portfolio
  66. 8.11.5 Medtronic Recent Developments
  67. 8.12 Smith & Nephew
  68. 8.12.1 Smith & Nephew Company Information
  69. 8.12.2 Smith & Nephew Business Overview
  70. 8.12.3 Smith & Nephew Hemostatic and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Smith & Nephew Hemostatic and Tissue Sealing Agents Product Portfolio
  72. 8.12.5 Smith & Nephew Recent Developments
  73. 8.13 Cohera Medical
  74. 8.13.1 Cohera Medical Company Information
  75. 8.13.2 Cohera Medical Business Overview
  76. 8.13.3 Cohera Medical Hemostatic and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cohera Medical Hemostatic and Tissue Sealing Agents Product Portfolio
  78. 8.13.5 Cohera Medical Recent Developments
  79. 8.14 Shanghai Haohai Biological Technology Co. Ltd.
  80. 8.14.1 Shanghai Haohai Biological Technology Co. Ltd. Company Information
  81. 8.14.2 Shanghai Haohai Biological Technology Co. Ltd. Business Overview
  82. 8.14.3 Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Product Portfolio
  84. 8.14.5 Shanghai Haohai Biological Technology Co. Ltd. Recent Developments
  85. 8.15 Shandong Saikesaisi Biotechnology Co., Ltd
  86. 8.15.1 Shandong Saikesaisi Biotechnology Co., Ltd Company Information
  87. 8.15.2 Shandong Saikesaisi Biotechnology Co., Ltd Business Overview
  88. 8.15.3 Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Product Portfolio
  90. 8.15.5 Shandong Saikesaisi Biotechnology Co., Ltd Recent Developments
  91. 8.16 Chang ShaHai Run biological technology Co, LTD
  92. 8.16.1 Chang ShaHai Run biological technology Co, LTD Company Information
  93. 8.16.2 Chang ShaHai Run biological technology Co, LTD Business Overview
  94. 8.16.3 Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Product Portfolio
  96. 8.16.5 Chang ShaHai Run biological technology Co, LTD Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hemostatic and Tissue Sealing Agents Value Chain Analysis
  2. 9.1.1 Hemostatic and Tissue Sealing Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hemostatic and Tissue Sealing Agents Production Mode & Process
  6. 9.2 Hemostatic and Tissue Sealing Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hemostatic and Tissue Sealing Agents Distributors
  9. 9.2.3 Hemostatic and Tissue Sealing Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst